Coordination Center Notice of Intent 2

Non-competitive Notice of Intent Synopsis
Type: Special Notice
Notice Number: 75N98026R00176
Title: National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation Funnel Coordination Center
Classification Code: A – Research & Development
NAICS Code: 541614 - Process, Physical Distribution and Logistics Consulting Services Posted Date: October 16, 2026
Response Date: November 2, 2026
Primary Point of Contact: Melanie Suarez, Contracting Officer, [email protected]

INTRODUCTION

THIS SYNOPSIS IS A NON-COMPETITIVE NOTICE OF INTENT TO AWARD A MODIFICATION TO

INCREASE THE INDEFINITE-DELIVERY/INDEFINITE-QUANTITY (IDIQ) CEILING OF CONTRACT NO.

75N92022D00014 WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING

BRAND-NAME).
This acquisition is conducted under the authority of 41 United States Code (U.S.C.) 3304(a)(1), as set forth in RFO – Federal Acquisition Regulation (FAR) 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The National Institute of Biomedical, Imaging, and Bioengineering (NIBIB) intends to award a modification to Indefinite-Delivery/Indefinite-Quantity (IDIQ) Contract No. 75N92022D00014, facilitating the requirements of the Rapid Acceleration of Diagnostics (RADx-Tech) initiative, an innovation funnel aimed at increasing the speed of development, commercialization, and implementation of health technologies, without providing for full and open competition (including brand-name) to the Massachusetts General Hospital Consortia for Improving Medicine with Innovation and Technology (CIMIT). The IDIQ ceiling value for Contract No. 75N92022D00014 will be increased through a modification action to accommodate and to continue core operational activities outlined in the Statement of Work (SOW). It is anticipated that the modification will be issued around December 2026. THIS IS A SYNOPSIS. THIS IS NOT A SOLICITATION.

BACKGROUND AND PROGRAM OBJECTIVES

In response to the COVID-19 pandemic, the NIBIB created the Rapid Acceleration of Diagnostics (RADx-Tech) initiative, an innovation funnel aimed at increasing the speed of development, commercialization, and implementation of technologies for COVID-19 testing. The RADx-Tech innovation funnel was designed to compress the customary technology development timeline from years down to just months. This was accomplished by employing, in parallel, expert teams of contracted consultants to assist technology developers in addressing technical, regulatory,